Harvard Business Review

MARCH 14, 2017

For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. Yet they have already generated tens of millions of dollars in value for Roivant.

Innovation 9

Innovation Company Incentives Industry 9

Harvard Business Review

JUNE 9, 2017

Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. During our careers, we have worked in industry, academia, clinical medicine, and government and have managed successful academia-industry collaborations.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

FEBRUARY 21, 2012

Having a strong domestic manufacturing base is vital to the United States maintaining its world leadership in innovation. Since joining the Harvard Business School in 2007 (after a long career at IBM, Kodak, Silicon Graphics, and other companies), I have visited hundreds of factories. When R&D and Manufacturing Must Be Near.

Supply Chain 15

Supply Chain Offshoring Engineering Pharmaceuticals 15

Harvard Business Review

DECEMBER 27, 2016

But we would argue that credibility may also be signaled to important external stakeholders — future employees, patients, the pharmaceutical industry, donors, and so on. The course culminates in a team-based innovation project presented to hospital leadership. …and how training can make them even better ones.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

MARCH 6, 2012

Technological innovation accounted for almost half of U.S. economic growth over the past 50 years, but the country's standing as the world's indisputable innovation leader is now at risk. We must inspire students to find value in pursuing a career in science. Their inspiring and visionary approach helps drive business growth.

Education 12

Education Creativity How To Pharmaceuticals 12

Harvard Business Review

SEPTEMBER 5, 2013

When we interviewed 45 such people across 39 companies in 8 industries in the United States and Europe, we found that by identifying low-value tasks to either drop completely, delegate to someone else or outsource, the average worker gained back roughly one day a week they could use for more important tasks.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. The data captured a 20-year period, from 1995 to 2014.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 12

Innovation Supply Chain Offshoring Policies 12

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. Take a look at any significant innovation, such as an iPhone , and you’ll find that most, if not all, of the technology came from some government program. In the pharmaceutical industry, the monitoring process can be incredibly elaborate. vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8